LED Dental sets June 30 launch for VELscope Mantis oral screening device

By AI, Created 6:46 PM UTC, June 03, 2026, /AGP/ – LED Dental says the cordless VELscope Mantis will ship June 30 through distributors in the U.S. and Canada. The redesigned oral screening device combines fluorescence, polarized reflectance and photo documentation in one handpiece as dental professionals look for earlier signs of mucosal abnormalities.

Why it matters: - Oral cancer is difficult to catch early because initial lesions can show only subtle tissue changes. - Earlier detection can improve outcomes, with five-year survival rates exceeding 80% for early-stage diagnoses. - LED Dental is positioning the VELscope Mantis as a chairside tool that can add more visual information during routine oral exams.

What happened: - LED Dental announced that the VELscope Mantis will be available beginning June 30, 2026. - The launch covers authorized distributors in the United States and Canada. - Pre-orders are open now. - Dental professionals can pre-order the device, schedule a demonstration, or learn more at velscope.com.

The details: - The VELscope Mantis is a ground-up redesign of LED Dental’s fluorescence visualization platform. - The device combines three visualization modes in one cordless, rechargeable handpiece. - Blue-light fluorescence visualization highlights areas where tissue fluorescence is diminished or altered, which may indicate dysplasia, inflammation or other abnormalities. - Polarized white-light reflectance removes back reflectance and surface glare to improve color response and help clinicians see subtle color changes. - Traditional white-light illumination provides surgical-quality lighting and removes the need for a separate overhead light source during screening. - The device has a wider field of view, allowing clinicians to evaluate more tissue in each pass and reduce repositioning during a full oral exam. - Enhanced image filtering produces brighter fluorescence images with increased yellow and orange spectral content, which improves visualization of bacterial presence. - An iPhone adapter built into the system supports photo documentation during screening. - The documentation workflow is designed to help with case tracking, patient education and referral communication without separate imaging hardware. - The rechargeable battery design eliminates power cord constraints and supports movement between operatories. - The handpiece is designed for single-handed use during extended screening sessions. - The Mantis is non-invasive, does not require dyes or rinses, and takes just a few minutes to use. - The system includes the Mantis handpiece with rechargeable battery, patient safety glasses and a documentation package. - Mantis Shield disposable barriers are sold separately. - Authorized distribution includes Patterson Dental, Henry Schein, Henry Schein Canada, Benco Dental, Darby Dental, DuraPro Health, Diamond Dental, Dental Sales Solutions, Sinclair Dental and VELscopeshop.com. - LED Dental also offers a complimentary 2-hour continuing education certification program for VELscope users at velscope.com.

Between the lines: - The Mantis name references the mantis shrimp, which sees ultraviolet, infrared and polarized light across 16 types of photoreceptors. - That comparison underscores the product pitch: more visual channels may help clinicians spot subtle tissue changes that standard white light can miss. - Wayne Rees, CEO of LED Dental, said the device is not a replacement for clinical judgment and is meant to provide additional tools for visualizing tissue change.

What’s next: - LED Dental says the product will reach distributors starting June 30, 2026. - The company is steering clinicians to its website for demonstrations, enrollment and product information. - The continuing education program suggests LED Dental is also aiming to support adoption after launch.

The bottom line: - LED Dental is betting that a cordless, multi-mode oral screening device can make routine dental exams more useful for spotting possible oral mucosal abnormalities earlier.